PHILIP MORRIS INTERNATIONAL ($PM) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $1.69 per share, beating estimates of $1.66 by $0.03. The company also reported revenue of $9,301,000,000, missing estimates of $9,398,265,900 by $-97,265,900.
You can see Quiver Quantitative's $PM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PHILIP MORRIS INTERNATIONAL Insider Trading Activity
PHILIP MORRIS INTERNATIONAL insiders have traded $PM stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $PM stock by insiders over the last 6 months:
- ANDRE CALANTZOPOULOS has made 0 purchases and 2 sales selling 142,561 shares for an estimated $19,292,297.
- JACEK OLCZAK (Chief Executive Officer) sold 40,000 shares for an estimated $5,954,800
- WILDE FREDERIC DE (Pr SSEA CIS & MEA Region) has made 0 purchases and 2 sales selling 40,000 shares for an estimated $5,442,100.
- EMMANUEL BABEAU (Chief Financial Officer) sold 30,000 shares for an estimated $4,465,500
- MASSIMO ANDOLINA (President, Europe Region) sold 17,500 shares for an estimated $2,730,875
- WERNER BARTH (Pr.Combusibles&GlobalComb.Mktg) has made 0 purchases and 2 sales selling 17,500 shares for an estimated $2,461,549.
- STEFANO VOLPETTI (Pr.SmokeFree&ChiefCons.Officer) sold 10,000 shares for an estimated $1,324,800
- REGINALDO DOBROWOLSKI (Vice President and Controller) has made 0 purchases and 2 sales selling 8,000 shares for an estimated $1,197,630.
- LARS DAHLGREN (Pres. Smoke-Free Oral Products) sold 3,679 shares for an estimated $562,739
- YANN GUERIN (SVP & General Counsel) sold 2,500 shares for an estimated $378,200
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PHILIP MORRIS INTERNATIONAL Hedge Fund Activity
We have seen 1,162 institutional investors add shares of PHILIP MORRIS INTERNATIONAL stock to their portfolio, and 955 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC added 6,092,558 shares (+14.3%) to their portfolio in Q4 2024, for an estimated $733,239,355
- CAPITAL RESEARCH GLOBAL INVESTORS removed 5,494,118 shares (-9.8%) from their portfolio in Q4 2024, for an estimated $661,217,101
- CAPITAL INTERNATIONAL INVESTORS removed 4,835,948 shares (-5.0%) from their portfolio in Q4 2024, for an estimated $582,006,341
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 4,298,530 shares (+372.2%) to their portfolio in Q4 2024, for an estimated $517,328,085
- CAPITAL WORLD INVESTORS added 4,216,586 shares (+3.6%) to their portfolio in Q4 2024, for an estimated $507,466,125
- VIKING GLOBAL INVESTORS LP removed 3,964,533 shares (-43.8%) from their portfolio in Q4 2024, for an estimated $477,131,546
- BLACKROCK, INC. added 3,227,263 shares (+3.2%) to their portfolio in Q4 2024, for an estimated $388,401,102
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PHILIP MORRIS INTERNATIONAL Congressional Stock Trading
Members of Congress have traded $PM stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PM stock by members of Congress over the last 6 months:
- REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 02/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PHILIP MORRIS INTERNATIONAL Analyst Ratings
Wall Street analysts have issued reports on $PM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 04/16/2025
- Barclays issued a "Overweight" rating on 01/08/2025
To track analyst ratings and price targets for PHILIP MORRIS INTERNATIONAL, check out Quiver Quantitative's $PM forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
